Biodesix (BDSX) Invested Capital (2019 - 2026)

Biodesix (BDSX) has reported Invested Capital for 8 consecutive years, with $9.1 million the latest figure, recorded in Q1 2026.

• Invested Capital for Q1 2026 came in at $9.1 million, down 17.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.1 million (down 17.43% YoY), and the FY2025 annual result was -$2.5 million, down 111.81% from the prior year.
• Invested Capital was $9.1 million for Q1 2026 at Biodesix, up from -$2.5 million in the prior quarter.
• Over five years, Invested Capital peaked at $42.1 million in Q2 2024 and troughed at -$2.5 million in Q4 2025.
• Average Invested Capital over 5 years is $15.8 million, with a median of $15.8 million recorded in 2022.
• Year-over-year, Invested Capital jumped 456.26% in 2024 and sank 111.81% in 2025.
• Over 5 years, Invested Capital stood at $30.9 million in 2022, then declined by 14.57% to $26.4 million in 2023, then decreased by 21.03% to $20.9 million in 2024, then slumped by 111.81% to -$2.5 million in 2025, then soared by 470.47% to $9.1 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $9.1 million in Q1 2026, -$2.5 million in Q4 2025, and -$1.7 million in Q3 2025.